Volume 20; Issue 4

Journal of Medical Economics

Volume 20; Issue 4

1

Economic evaluation for the US of nab-paclitaxel plus gemcitabine versus FOLFIRINOX versus gemcitabine in the treatment of metastatic pancreas cancer

Gharaibeh, Mahdi, McBride, Ali, Bootman, J. Lyle, Patel, Hitendra, Abraham, Ivo

Journal:

Journal of Medical Economics

Year:

2017

Language:

english

File:

PDF, 1.03 MB

english, 2017

2

Continuous prophylaxis with recombinant factor IX Fc fusion protein and conventional recombinant factor IX products: comparisons of efficacy and weekly factor consumption

Iorio, Alfonso, Krishnan, Sangeeta, Myrén, Karl-Johan, Lethagen, Stefan, McCormick, Nora, Yermakov, Sander, Karner, Paul

Journal:

Journal of Medical Economics

Year:

2017

Language:

english

File:

PDF, 947 KB

english, 2017

3

The economic impact of insulin-related hypoglycemia in Denmark: an analysis using the Local Impact of Hypoglycemia Tool

Hoskins, Nicki, Tikkanen, Christian Klyver, Pedersen-Bjergaard, Ulrik

Journal:

Journal of Medical Economics

Year:

2017

Language:

english

File:

PDF, 1.08 MB

english, 2017

4

Societal implications of medical insurance coverage for imatinib as first-line treatment of chronic myeloid leukemia in China: a cost-effectiveness analysis

Sheng, Guangying, Chen, Suning, Dong, Chaohui, Zhang, Ri, Miao, Miao, Wu, Depei, Tan, Seng Chuen, Liu, Chao, Xiong, Tengbin

Journal:

Journal of Medical Economics

Year:

2017

Language:

english

File:

PDF, 814 KB

english, 2017

5

The impact of medical insurance coverage and molecular monitoring frequency on outcomes in chronic myeloid leukemia: real-world evidence in China

Sheng, Guangying, Chen, Suning, Zhang, Ri, Miao, Miao, Wu, Depei, Tan, Seng Chuen, Liu, Chao, Xiong, Tengbin

Journal:

Journal of Medical Economics

Year:

2017

Language:

english

File:

PDF, 628 KB

english, 2017

6

Budget impact of everolimus for the treatment of progressive, well-differentiated, non-functional neuroendocrine tumors of gastrointestinal or lung origin that are advanced or metastatic

Rose, Darya B., Nellesen, Dave, Neary, Maureen P., Cai, Beilei

Journal:

Journal of Medical Economics

Year:

2017

Language:

english

File:

PDF, 742 KB

english, 2017

7

Economic burden of inadequate symptom control among US commercially insured patients with irritable bowel syndrome with diarrhea

Buono, Jessica L., Mathur, Kush, Averitt, Amelia J., Andrae, David A.

Journal:

Journal of Medical Economics

Year:

2017

Language:

english

File:

PDF, 1.40 MB

english, 2017

8

Healthcare utilization and costs in patients with tuberous sclerosiscomplex-related renal angiomyolipoma

Song, Xue, Liu, Zhimei, Cappell, Katherine, Gregory, Christopher, Said, Qayyim, Prestifilippo, Judith, Charles, Hearns, Hulbert, John, Bissler, John

Journal:

Journal of Medical Economics

Year:

2017

Language:

english

File:

PDF, 677 KB

english, 2017

9

The 21st Century Cures Act: pharmacoeconomic boon or bane?

Mendoza, Roger Lee

Journal:

Journal of Medical Economics

Year:

2017

Language:

english

File:

PDF, 601 KB

english, 2017

10

Costs of providing infusion therapy for patients with inflammatory bowel disease in a hospital-based infusion center setting

Afzali, Anita, Ogden, Kristine, Friedman, Michael L., Chao, Jingdong, Wang, Anthony

Journal:

Journal of Medical Economics

Year:

2017

Language:

english

File:

PDF, 855 KB

english, 2017

11

Cost-effectiveness and sustainability of breast cancer screening and new anti-cancer drugs

Mustacchi, Giorgio, Generali, Daniele

Journal:

Journal of Medical Economics

Year:

2017

Language:

english

File:

PDF, 698 KB

english, 2017

12

Comparison of economic and clinical outcomes between patients undergoing laparoscopic bariatric surgery with powered versus manual endoscopic surgical staplers

Roy, Sanjoy, Yoo, Andrew, Yadalam, Sashi, Fegelman, Elliott J., Kalsekar, Iftekhar, Johnston, Stephen S.

Journal:

Journal of Medical Economics

Year:

2017

Language:

english

File:

PDF, 1.23 MB

english, 2017